FdaApplication
NDA 211616
Identifiers
- fda_app_no: NDA211616
Properties
| Property | Value |
|---|---|
| applicant_name | ESPERION THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2020-02-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXLETOL | BEMPEDOIC ACID | 180MG | TABLET;ORAL |
1 product